New ground is often best trodden together. Where it is possible and makes sense, we work in coalition with co-investors.


Companies with the future in common.

Each company in our portfolio has something in common. The future.

 

Each has broken with convention, imagined the future differently, and developed products and services that reach far beyond accepted norms of performance. As you will see from our portfolio, this thinking has expressed itself in breakthrough materials, in revolutionary processes, in imaginative new services. Roll over the companies here for a brief overview on how they are contributing to that future.

Technolas Perfect Vision
From Munich, Technolas Perfect Vision, is the only global pure play refractive surgery business. With INTRACOR, it’s leading edge non-invasive (intrastromal) refractive surgery, it is redefining what is possible in ophthalmic surgery.
CPT
The automotive industry’s drive to reduce CO2 emissions is the focus of Controlled Power Technologies. It acquires licensed technologies such as micro-hybrid start-stop systems and exhaust gas energy recovery systems and focuses their potential on this growing need.
d3o
Imagine a material made from intelligent molecules that could flow as you moved, but on shock would lock together to absorb the energy of the impact. That is d3o. Of this material’s many applications, the d3o lab is currently working in human body protection.
Exosect
Swiss listed company Evolva (EVE) uses its proprietary synthetic biology platform to create innovative small molecule drugs for third parties and for own clinical development.
Exosect
Exosect develops and sells Intelligent Pest Management solutions, giving growers, food producers and processors a cost-effective way to reduce insecticide use. Its ambition is to help growers achieve zero residues in their crops.
FutureE
Modular fuel cell solutions for individual power requirements. FutureE is about customization, flexibility, reliability and durability. The remotely monitored modular plug-and-play system minimizes service requirements.
General Fusion
This Canadian start up is developing relatively low-tech fusion energy technology. General Fusion is applying the latest in material technology and digital signal processing to MTF, a 30 year old approach which had largely been ignored in recent years.
inge
Purifying, protecting and preserving valuable water resources is inge’s passion. Its proprietary UF membrane technology provides drinking water free from bacteria and viruses. The universal need for safe water means the company markets its technology worldwide.
Lifeline Scientific (formerly ORS)
Today, the standard method for kidney preservation and transport is a cooler or cardboard box with ice. Lifeline Scientific’s lead product is set to bring organ transport into a new era. Its portable machine perfusion device is FDA approved, CE marked, clinically validated and already generates revenue.
n-Tec
The founders of this 2001 start-up use their mix of industrial and academic backgrounds to bring to market high quality carbon nanotubes, carbon cones and related carbon nanomaterials.
OptiNose
Nasal delivery of vaccines and drugs is a user-friendly alternative to injections and a fast alternative to oral administration. Optinose has developed a range of breath actuated devices for bidirectional delivery and has used these to build a solid clinical pipeline.
Prosonix
Acknowledged leaders in the commercialisation of proprietary ultrasonic particle engineering technologies and added value ultrasonic process chemistry solutions for the pharmaceutical and related industries.
ProtAffin
This pre-clinical biotechnology company develops protein-based products countering inflammation. Its novel class of biologics targets the heparin-like glycan structures that drive inflammatory processes.
Stellacure
A true first. This is the first public-private umbilical stem cell storage bank. Stellacure works in close cooperation with the German Red Cross.
t2cure
With the emphasis on ‘cure’, this company is dedicated to the development of novel progenitor cell-based regenerative therapeutics. It seeks to provide new treatment options to patients suffering from cardiac or peripheral vascular diseases.
Vasopharm
This German biopharmaceutical company is dedicated to the discovery and development of novel therapeutics to treat cerebro- and cardiovascular diseases and their consequences.
Zeroshift Ltd
Focussed on performance in all senses, this is the world’s most advanced Automated Manual Transmission (AMT). Zeroshift technology is a seamless, instantaneous means of changing gear ratios without interrupting engine torque to the wheels.